期刊文献+

钙激活蛋白酶Ⅰ在风湿性心脏病心房颤动中的作用 被引量:1

Effects of Calpain Ⅰ on atrial fibrillation patients with rheumatic heart disease
下载PDF
导出
摘要 目的:阐明风湿性心脏病中钙激活蛋白酶Ⅰ(Calpain Ⅰ)与心房颤动(AF)关系及Calpain Ⅰ在风湿性心脏病不同类型心房颤动时的变化特点。方法:选择心脏手术患者55 例,共分为4 组,A组(n=12):非风湿性心脏病窦性心律组;B组(n=13):风湿性心脏病窦性心律组;C组(n=14):风湿性心脏病阵发性AF组;D组(n=16):风湿性心脏病持续性AF组。在患者右房侧壁组织蛋白提取液不加钙离子或加钙离子(10-3mol/L)的条件下,采用比色法,对非选择性蛋白酶抑制剂E 64、Calpain Ⅰ抑制剂、Calpain Ⅱ抑制剂、溶酶体抑制剂Lactocystin作用于心房肌组织后的蛋白裂解活性进行检测比较。结果:A组、B组在相同试验条件下蛋白裂解活性未见明显差异;不给予蛋白酶抑制剂时, C组、D组的蛋白裂解活性明显高于B组(P<0.01);给予蛋白酶抑制剂,Calpain Ⅰ抑制剂可抑制4组患者心肌组织蛋白裂解活性,而CalpainⅡ抑制剂则不能充分抑制4组患者心肌组织蛋白裂解活性。结论:风心病心房颤动患者心肌组织蛋白裂解活性是升高的,其活性升高与Calpain Ⅰ的作用有密切关系。 Objective:To study the relationship between Calpain Ⅰ and atrial fibrillation in patients with rheumatic heart disease(RHD) and to study Calpain Ⅰ changes in different type of atrial fibrillation. Methods: Fifty patients underwent heart surgery were divided into 4 group. Group A(n=12): Sinus rhythm group without rheumatic heart diseases; Group B(n=13): Sinus rhythm group with RHD; Group C(n=14): Paroxysmal AF with RHD; Group D(n=16): Persistent AF group with RHD.Atrial proteolytic activities in 4 groups were compared with and without Ca 2+ by colorimetric method after atrial myocardial tissue was treated with E-64, Calpain Ⅰ inhibitor,Calpain Ⅱ inhibitor and Lactocystin. Results: No significant differences of proteolytic activities were found between group A and group B under the same condition. Proteolytic activities in group C and group D were significantly higher than those in group B(P<0.01). Calpain Ⅰ inhibitor inhibited atrial proteolytic activities whereas Calpain Ⅱ inhibitor did not. Conclusion: Proteolytic activity increases in atrial fibrillation patients with RHD and the increases has close relationship with Calpain Ⅰ.
出处 《第二军医大学学报》 CAS CSCD 北大核心 2005年第2期134-135,共2页 Academic Journal of Second Military Medical University
基金 国家自然科学基金 (30070749)
关键词 风湿性心脏病 心房颤动 钙激活蛋白酶Ⅰ 蛋白裂解活性 rheumatic heart disease atrial fibrillation Calpain Ⅰ proteolytic activity
  • 相关文献

参考文献6

  • 1Goette A, Honeycutt C, Langberg JJ. Electrical remodeling in atrial fibrillation: time course and mechanisms [J]. Circulation, 1996, 94(11): 2968-2974.
  • 2Gao WD, Atar D, Liu Y,et al. Role of troponin I proteolysis in the pathogenesis of stunned myocardium [J]. Circ Res, 1997, 80(3): 393-399.
  • 3Urthaler F, Wolkowicz P, Dignerness S, et al. MDL-28170, a membrane-permeant calpain inhibitor, attenuates stunning and PKC epsilon proteolysis in reperfused ferret hearts [J]. Cardiovasc Res, 1997, 35(1): 60-67.
  • 4Brundel BJJM, Ausma J, van Gelder IC, et al. Activation of proteolysis by calpains and structural changes in human paroxysmal and persistent atrial fibrillation[J]. Cardiovasc Res, 2002, 54(2):380-389.
  • 5Brundel BJJM, Henning RH, Kampinga HH, et al. Molecular mechanisms of remodeling in human atrial fibrillation[J]. Cardiovasc Res, 2002, 54(2):315-324.
  • 6Brundel BJJM, Kampinga HH, Henning RH. Calpain Ⅰnhibition prevents pacing-induced cellular remodeling in a HL-1 myocyte model for atrial fibrillation[J]. Cardiovasc Res,2004, 62(3):521-528.

同被引文献2

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部